Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization-Reference-Cited by-同舟云学术

Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization

Published:2023-03 Issue:14 Volume:41 Page:2329-2338
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Feikin Daniel R.,Higdon Melissa M.,Andrews Nick,Collie Shirley,Deloria Knoll Maria,Kwong Jeffrey C.,Link-Gelles Ruth,Pilishvili Tamara,Patel Minal K.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference44 articles.

1. World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. World Health Organization 2021; published online Nov 26. Available from: https://www.who.int/news/item/26-11-2021-classification-of-Omicron-(b.1.1.529)-sars-cov-2-variant-of-concern (accessed Dec. 26, 2022).

2. United Kingdom Health Security Agency. COVID-19 vaccine surveillance report - week 50. United Kingdom Health Security Agency 2021; published online Dec 12. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1041593/Vaccine-surveillance-report-week-50.pdf (accessed Jan. 23, 2023).

3. Sheikh A, Kerr S, Woolhouse M, et al. Severity of Omicron variant of concern and vaccine effectiveness against symptomatic disease: national cohort with nested test negative design study in Scotland. University of Edinburgh 2021; published online Dec 22. https://www.research.ed.ac.uk/en/publications/severity-of-Omicron-variant-of-concern-and-vaccine-effectiveness- (preprint)

4. Hansen CH, Schelde AB, Mousten-Helm IR, et al. Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study. medRxiv 2021; published online Dec 23. doi: 10.1101/2021.12.20.21267966. (preprint).

5. Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes;Buchan;JAMA Netw Open,2022

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and outcomes in adults with COVID-19 during the pre-Omicron and Omicron waves;Infectious Diseases Now;2024-03

2. Immunogenicity, clinical efficacy and safety of additional second COVID‐19 booster vaccines against Omicron and its subvariants: A systematic review;Reviews in Medical Virology;2024-01

3. Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives;Viruses;2023-12-25

4. Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults;Clinical Infectious Diseases;2023-11-24

5. Monitoring COVID‐19 vaccine effectiveness against COVID‐19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022;Influenza and Other Respiratory Viruses;2023-11